Company news
Shattuck Labs, Inc. news in 2025
Shattuck Labs, Inc.'s news releases, calls and decks from 2025, newest first.
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2025
Shattuck Labs to Participate in Upcoming December Investor Conferences
November 20, 2025
Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 6, 2025
Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel
October 2, 2025
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
August 26, 2025
Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease
August 21, 2025
Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights
August 14, 2025
Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million
August 5, 2025
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism
July 2, 2025
Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights
May 1, 2025
Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference
April 2, 2025
Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
March 27, 2025
Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
February 20, 2025
Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn’s and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
February 12, 2025
Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn’s and Colitis Congress
February 3, 2025
Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
January 5, 2025
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025
January 1, 2025
Decks in 2025
- Investor Presentation (November 2025)
Investor deck · 30 slides · Nov 6, 2025
- European Crohn's and Colitis Organization 2025
Conference · 9 slides · Feb 20, 2025